Alternative oxygen carriers

Current Opinion in Hematology

Volumn 3, Issue 6, 1996, Pages 492-497

  Hess, John R ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; ENDOTOXIN; FLUOROCARBON; FLUOSOL DA; FREE RADICAL; HEMOGLOBIN DERIVATIVE; NEUROTOXIN; NITRIC OXIDE; OXYGEN; PERFLUOROOCTANE; PERFLUOROOCTYL BROMIDE;

BACTERIAL INFECTION; CLINICAL TRIAL; COMPLEMENT ACTIVATION; EMULSION; GENETIC ENGINEERING; HEMORRHAGIC SHOCK; HUMAN; LIPID PEROXIDATION; LUNG INSUFFICIENCY; NONHUMAN; OXYGEN TRANSPORT; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW;

EID: 0029908788     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199603060-00016     Document Type: Review

References (58)

1. Winslow RM: Blood substitutes: a moving target. Nature Med 1995, 1:1212-1215.
2. Winslow RM, Vandegriff KD, Intaglietta M: Blood Substitutes: New Challenges. Boston: Birkhauser; 1996. Includes a list of almost all published papers on blood substitutes in 1995. These annual volumes contain reviews of many important scientific and some medical and social issues in blood substitutes research and development.
3. Brunori M, Cutruzzola F, Vallone B: Hemoglobin engineering for fun and money. Curr Biol 1995, 5:462-465.
4. Bunn HF: The use of hemoglobin as a blood substitute. Am J Hematol 1993, 42:112-117.
5. Dietz NM, Joyner MJ, Warner MA: Blood substitutes: fluids, drugs, or miracle solutions. Anesth Analg 1996, 82:390-405. Reviews the toxicities and pharmacology of hemoglobin solutions compared with the functional requirements for oxygen carriers in the common clinical indications.
6. Dracker RA: The development and use of oxygen-carrying blood substitutes. Immunol Invest 1995, 24:403-410.
7. Jones JA: Red blood cell substitutes: current status. Br J Anaesth 1995, 74:697-703.
8. Ogden JE, MacDonald SL: Hemoglobin-based red cell substitutes: current status. Vox Sang 1995, 69:302-308.
9. Ogden JE, Parry ES: The development of hemoglobin solutions as red cell substitutes. Int Anesthesiol Clin 1995, 33:115-129.
10. Rabinovici R, Neville LF, Rudolph AS, Feuerstein G: Hemoglobin-based oxygen carrying resuscitation fluids [editorial]. Crit Care Med 1995, 23:801-804.
11. Spiece BD: Perfluorocarbon emulsions: one approach to intravenous artificial respiratory gas transport. Int Anesthesiol Clin 1995, 33:103-113.
12. Hess JR: Review of modified hemoglobin research at Letterman: attempts to delineate the toxicity of cell-free tetrameric hemoglobin. Artif Cells Blood Substit Immobil Biotechnol 1995, 23:277-289.
13. Kaufman RJ: Clinical development of perfluorocarbon-based emulsions as red cell substitutes. In Current Issues in Blood Substitute Research: Physiological Basis of Efficacy. Edited by Winslow RM, Vandegriff KD, Intaglietta M. Boston: Birkhauser; 1995:53-75.
14. Zuck TF, Reiss JG: Current status of injectable oxygen carriers. Crit Rev Clin Lab Sci 1994, 31:295-324.
15. Spence RK, Norcross ED, Constabile J, McCoy S, Cernaianu AC, Alexander JB, Pello MJ, Atabek U, Camishion RC: Perfluorocarbons as blood substitutes: the early years. Experience with Fluosol DA-20% in the 1980s. Artif Cells Blood Substit Immobil Biotechnol 1994, 22:955-963.
16. Premaratne S, Harada RN, Chun P, Suehiro A, McNamara JJ: Effects of perfluorocarbon exchange transfusion on reducing myocardial infarct size in a primate model of ischemia-reperfusion injury: a prospective, randomized study. Surgery 1995, 117:670-676. Results suggest that the beneficial effects of exchange transfusion with perfluorocarbons may be primarily due to hemodilution, as exchange transfusion with emulsion was better than no treatment but not better than exchange with Ringer's lactate.
17. Keipert PE: Use of Oxygent™, a perfluorochemical-based oxygen carrier, as an alternative to intraoperative blood transfusion. Artif Cells Blood Substit Immobil Biotechnol 1995, 23:381-394.
18. Bleeker WK, Zappeij LM, den Boer PJ, Agterberg JA, Rigter GM, Bakker JC: Evaluation of the immunogenicity of polymerized hemoglobin in a rabbit model. Artif Cells Blood Substit Immobil Biotechnol 1995, 23:461-468.
19. Winslow RM: Hemoglobin-Based Red Cell Substitutes. Baltimore: Johns Hopkins University Press; 1992.
20. Hess JR, Macdonald VW, Brinkley WW: Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 1993, 74:1769-1778.
21. Murray JA, Ledlow A, Launspach J, Evans D, Loveday M, Conklin JL: The effects of recombinant human hemoglobin on esophageal motorfunctions in humans. Gastroenterology 1995, 109:1241-1249.
22. Olsen SB, Tang DB, Jackson MR, Gomez ER, Ayala B, Alving BM: Enhancement of platelet deposition by cross-linked hemoglobin in a rat carotid endarterectomy model. Circulation 1996, 93:327-332.
23. Motterlini R, Vandegriff KD, Winslow RM: Hemoglobin-nitric oxide interaction and its implications. Transfus Med Rev 1996, 10:77-84. Very good review of the mechanisms of hemoglobin's reactions with nitric oxide and how they may affect blood pressure control and peroxidative injury.
24. Katusic ZS, Lee HC, Clambey ET: Cross-linked hemoglobin inhibits endothellum dependent relaxations in isolated canine arteries. Gen Pharmacol 1996, 27:239-244.
25. Lee R, Neya K, Svizzero TA, Vlahakes GJ: Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions. J Appl Physiol 1995, 79:236-242. This study demonstrates the ability of a polymerized hemoglobin to cause systemic and pulmonary hypertension and increased vascular resistance, which in turn limit oxygen transport. It also shows the instability of polymerized hemoglobin with rapid conversion to methemoglobin.
26. Hughes GS, Francome SF, Antal EJ, Adams WJ, Locker FK, Yancey EP, Jacobs EE: Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects. J Lab Clin Med 1995, 126:444-451.
27. Balla J, Nath KA, Balla G, Juckett MB, Jacob HS, Vercellotti GM: Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo. Am J Physiol 1995, 268:L321-L327.
28. Cashon RE, Alayash AI: Reaction of human hemoglobin HbAo and two cross-linked derivatives with hydrogen peroxide: differential behavior of the ferryl intermediate. Arch Biochem Biophys 1995, 316:461-469.
29. Motterlini R, Foresti R, Vandegriff K, Intaglietta M, Winslow RM: Oxidative-stress response in vascular endothelial cells exposed to acellular hemoglobin solutions. Am J Physiol 1995, 269:H648-H655.
30. Rogers MS, Ryan BB, Cashon RE, Alayash AI: Effects of polymerization on the oxygen carrying and redox properties of diaspirin cross-linked hemoglobin. Biochim Biophys Acta 1995, 1248:135-142.
31. Biro GP, Ou C, Ryan-McFarlane C, Anderson PJ: Oxyradical generation after resuscitation of hemorrhagic shock with blood or stroma-free hemoglobin solution. Artif Cells Blood Substit Immobil Biotechnol 1995, 23:631-645.
32. Princemail J, Detry O, Philippart C, Defraingne, Franssen C, Burhop K, Deby C, Meurisse M, Lamy M: Diaspirin crosslinked hemoglobin (DCLHb™): absence of increased free radical generation following administration in a rabbit model of renal ischemia and reperfusion. Free Radic Biol Med 1995, 19:1-9.
33. Regan RF, Panter SS: Neurotoxicity of hemoglobin in cortical cell culture. Neurosci Lett 1993, 153:219-222.
34. McFaul SJ, Bowman PD, Villa VM, Gutierrez-Ibanez, Johnson M, Smith D: Hemoglobin stimulates mononuclear leukocytes to release interleukin-8 and tumor necrosis factor alpha. Blood 1994, 84:3175-3181.
35. Kaca W, Roth RI, Vandegriff KD, Chen GC, Kuypers FA, Winslow RM, Levin J: Effects of bacterial endotoxin on human cross-linked and native hemoglobins. Biochemistry 1994, 34:11176-11185.
36. Kaca W, Roth RI, Levin J: Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LPS biological activity. J Biol Chem 1994, 269:25078-25084.
37. Roth RI: Hemoglobin enhances the production of tissue factor by endothelial cells in response to bacterial endotoxin. Blood 1994, 83:2860-2865.
38. Su D, Roth RI, Levin J: Hemoglobin enhances the mortality from bacterial endotoxin [abstract #1767]. Blood 1995, 86:445a.
39. Griffiths E, Cortes A, Gilbert N, Stevenson P, MacDonald S, Pepper D: Hemoglobin based blood substitutes and sepsis. Lancet 1995, 345:158-160.
40. Hughes GS, Yancey EP, Albrecht R, Locker PK, Francome SF, Orringer EP, Antal EJ, Jacobs EE: Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans. Clin Pharmacol Ther 1995, 58:434-443.
41. Sharma AC, Gulati A: Yohimbine modulates diaspirin crosslinked hemoglobin induced systemic hemodynamics and regional circulatory effects. Crit Care Med 1995, 23:874-884.
42. Matheson-Urbaitis B, Lu YS, Fronticelli C, Bucci E: Renal and systemic-hemodynamic response to isovolemic exchange transfusion with hemoglobin cross-linked with bis(3,5-bromosalicyl) fumarate or albumin. J Lab Clin Med 1995, 126:250-260.
43. Dunlop E, Farrell L, Nigro C, Estep T, Marchand G, Burhop K: Resuscitation with diaspirin crosslinked hemoglobin in a pig model of hemorrhagic shock. Artif Cells Blood Substit Immobil Biotechnol 1995, 23:39-61.
44. Song D, Olano M, Wilson DF, Pastuszko A, Tammela O, Nho K, Shore RGL: Comparison of the efficacy of blood and polyethylene glycolhemoglobin in recovery of newborn piglets from hemorrhagic hypotension: effect on blood pressure, cortical oxygen, and extracellular dopamine in the brain. Transfusion 1995, 35:552-558.
45. Frankel HL, Nguyen HB, Shea-Donahue T, Aiton LA, Ratigon J, Malcolm DS: Diaspirin cross-linked hemoglobin is efficacious in gut resuscitation as measured by GI tract optrode. J Trauma 1996, 40:231-240.
46. Hindman J, Dexter F, Cutkomp J, Smith T: Diaspirin cross-linked hemoglobin does not increase brain oxygen consumption during hypothermic cardiopulmonary bypass in rabbits. Anesthesiology 1995, 83:1302-1311.
47. Kerger H, Torres Filho IP, Rivas M, Winslow RM, Intaglietta M: Systemic and subcutaneous microvascular oxygen tension in conscious Syrian golden hamsters. Am J Physiol 1995, 268:H802-H810.
48. Kida Y, Yamakawa T, Iwasaki S, Furusho N, Kadowaki Y, Iwate S, Iwashita Y, Nishi K: Interarterial perfusion of the hindlimb with pyridoxalated hemoglobin polyoxyethylene conjugate solution in anesthetized dogs. Artif Organs 1995, 19:511-518.
49. Schultz SC, Powell CC, Bernard E, Malcolm D: Diaspirin crosslinked hemoglobin (DCLHb) attenuates bacterial translocation in rats. Artif Cells Blood Substit Immobil Biotechnol 1995, 23:647-664.
50. Waschke KF, Albrect DM, van Ackern K, Kuschinsky W: Autoradiographic determination of regional cerebral blood flow and metabolism in conscious rats after fluid resuscitation from hemorrhage with a haemoglobin-based oxygen carrier. Br J Anaesth 1994, 73:522-528.
51. 2 uptake of working in situ dog muscle. Adv Exp Med Biol 1994, 361:375-378.
52. Eich RF, Li T, Lemon DD, Doherty DH, Curry SR, Aitken JF, Mathews AJ, Johnson KA, Smith RD, Phillips GN Jr, Olson JS: Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry 1996, 35:6976-6983.
53. Goins B, Klipper R, Sanders J, Cliff RO, Rudloph AS, Phillips WT: Physiologic responses, organ distribution, and circulation kinetics in anesthetized rats after hypovolemic exchange transfusion with technetium 99m-labeled liposome-encapsulated hemoglobin. Shock 1995, 4:121-130.
54. Jia L, Bonaventura C, Bonaventura J, Stamler JS: S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996, 380:221-226.
55. Kumar R: Recombinant hemoglobins as blood substitutes: a biotechnology prospective. Proc Soc Exp Biol Med 1995, 208:150-158.
56. Pietrforte D, Mallozzi C, Scorza G, Minetti M: The role of thiols in the targeting of S-nitrosothiols to red blood cells. Biochemistry 1995, 34:7177-7185.
57. Quebec EA, Chang TMS: Superoxide dismutase and catalase cross-linked to polyhemoglobin reduces methemoglobin formation in vitro. Artif Cells Blood Substit and Immobil Biotechnol 1995, 23:693-705.
58. Sloand EM, Pitt E, Klein HG: Safety of the blood supply. JAMA 1995, 274:1368-1373.